Sykesville, MD, and Fairfax, VA, December 21, 2020 – Noble Life Sciences (NLS), a preclinical contract research organization located in Sykesville, MD, has signed a Collaboration Agreement with George Mason University (Mason) to access the National Center for Biodefense and Infectious Diseases (NCBID) BSL-3 facility located within their Biomedical Research Laboratory at Mason’s Science and Technology Campus in Manassas. The Agreement enables NLS to perform federal and non-federally funded BSL-3 animal model projects to support the development of new antiviral and antibacterial agents against infectious and resistant pathogens.
{iframe}http://www.biohealthcapital.com/news/noble-life-sciences-announces-its-collaboration-with-george-mason-university-to-access-the-national-center-for-biodefense-and-infectious-diseases-bsl-3-facility/?utm_source=dlvr.it&utm_medium=linkedin{/iframe}